

Hypocritical U.S. Patent 6630507 on CBD Contradicts the Known Benefits of Cannabis and the Long-Known History of Medical Marijuana Use
U.S. Patent 6630507 and the Schedule-One contradiction, a tale of hypocrisy.
U.S. Patent 6630507 and the Schedule-One contradiction, a tale of hypocrisy.
By Doug Fine I missed out on an $8,000 one-day profit several weeks ago when I declined an opportunity to invest in British-based GW Pharmaceuticals,
By TruthOnPot.Com It seems like one of the greatest fears of the medical marijuana community is slowly being realized, as corporations quickly adopt cannabinoids into
As the medical benefits of marijuana are becoming more accepted in America, there is a rush to patent procedures and products that deal with cannabinoids.
Explain Why There Is A Government Held Patent Acknowledging Marijuana’s Medical Benefit The federal government refuses to admit that marijuana has medical benefits when it
Weed The People: Upset Pro Marijuana Vote Could Cost Obama The Election by Monterey Bud As many polling outfits struggle with tracking the presidential race…
By Lanny Swerdlow, RN, LNC Next year, the patent on Marinol–the synthetic version of THC–comes to an end, opening the market for synthetic THC distribution
Subscribe to stay up-to-date with the latest weed news
Subscribe to stay up-to-date with the latest weed news